Trilo Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Trilo Therapeutics, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include TRILOMER and DEGRADOMER. The owner is based in Belmont, CA.
2723 Monserat Ave
Belmont, CA 940021447
Showing of trademarks Trademarks
Trademark Classifications
Trilo Therapeutics, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Trilo Therapeutics, Inc. have?
Trilo Therapeutics, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Trilo Therapeutics, Inc. file in?
Trilo Therapeutics, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Trilo Therapeutics, Inc.'s most well-known trademarks?
Trilo Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as TRILOMER and DEGRADOMER. These are among 2 currently registered trademarks in the portfolio.
What is Trilo Therapeutics, Inc.'s trademark registration success rate?
Trilo Therapeutics, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.